Health
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2 – Technology Networks
Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they’re extracted from llamas and camels, which is problematic for…
Llamas, camels and COVID-19
For SARS-CoV-2 to infect humans, the viral Spike (S) protein must interact with and bind to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. The S protein achieves this via the receptor binding domains (RBDs), and thus blocking the RBD using antibodies is just one therapeutic avenue that is being explored for the treatment of SARS-CoV-2. Back in May, Technology Networks covered the work of scientists exploring the potential utility of…
-
General24 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Business24 hours agoWhy this ASX 200 stock could deliver a 30% return
-
Noosa News23 hours agoWoman charged with Mark Akers’s murder after body found on roadside
-
Noosa News24 hours agoWhere to Watch Live Music in Brisbane